On February 27, 2025, the Government of Canada and Manitoba signed the first national pharmacare agreements under ...

President Donald Trump imposed 25% tariffs on goods imported from Mexico and Canada, the United States’ two largest trading ...

When hostilities break out between individual co-trustees, incumbent trust counsel faces a representation conundrum. In §8.8 ...

Navigating a jury trial in an eminent domain case can feel like a high-stakes gamble. The unpredictability and inherent risks ...

The Corporate Transparency Act was passed in 2021 and took effect January 1, 2024. The purpose of the act is to help combat ...

The fate of the Corporate Transparency Act (CTA) has been anything but certain since the beneficial ownership information ...

Only a short time has elapsed since President Trump named Mark T. Uyeda as Acting Chair of the Securities and Exchange ...

The current administration’s whipsaw of imposed and withdrawn tariffs continues to rattle financial markets and industries ...

Every new presidential administration brings with it a degree of uncertainty regarding potential shifts in the Committee on ...

During his 2024 presidential campaign, Donald Trump made tariffs a cornerstone of his foreign and domestic policy. With new ...

Is it too soon for a BOI report obituary? After a recent declaration by the U.S. Department of Justice, the FinCEN Beneficial ...

This is part three of a series of executive orders related to health care. Halt all U.S. funding and resources to the WHO.